Print

Purpose

The purpose of this prospective study is to investigate whether ophthalmic artery stenosis (narrowing of the ophthalmic artery) contributes to the development and progression of geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD).

Condition

Eligibility

Eligible Ages
Between 50 Years and 80 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 50-80 years of age - All genders - Asymmetric dry AMD with geographic atrophy in at least one eye and reduced disease severity in the other eye according to International Classification of Disease (ICD) codes - Treated at the Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio

Exclusion Criteria

  • Poor image quality that limits quantification - GA extending beyond the borders of the SDOCT field of view. - Bilateral symmetric geographic atrophy. - Diagnosis of wet AMD. - Any retinal fluid at baseline. - Other concurrent retinal diseases - Vitreoretinal surgery. - Allergy to iodinated contrast agents. - Chronic kidney disease with eGFR < 60

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

Cleveland Clinic
Cleveland, Ohio 44195
Contact:
Sara Lautzenhiser Research Coordinator
216-444-3026
LAUTZES@ccf.org

More Details

Status
Recruiting
Sponsor
Scott Raymond

Study Contact

Sara Lautzenhiser Research Coordinator
216-444-3026
LAUTZES@ccf.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.